Ionis Pharmaceuticals informa las ganancias trimestralmente. Estos informes de ganancias trimestrales ofrecen a los inversores una visión de los resultados financieros de una empresa durante un período de 3 meses. Los informes de ganancias casi siempre incluyen resultados de EPS e ingresos.
Analice el historial de beneficios de Ionis Pharmaceuticals utilizando filtros y clasificaciones avanzadas.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
IONS | Ionis Pharmaceuticals | -$0.43 | -$1.25 | — | — | $227.00M | $151.89M | — | — | 02/18/2026 | |
IONS | Ionis Pharmaceuticals | -$0.72 | -$1.12 | -$0.61 | 45.27% | $134.00M | $130.27M | $157.00M | 20.52% | 10/29/2025 | |
IONS | Ionis Pharmaceuticals | -$0.24 | $0.16 | $0.85 | 431.25% | $225.00M | $287.69M | $452.00M | 57.11% | 07/30/2025 | |
IONS | Ionis Pharmaceuticals | -$0.77 | -$1.03 | -$0.93 | 9.71% | $119.00M | $122.51M | $132.00M | 7.75% | 04/30/2025 | |
IONS | Ionis Pharmaceuticals | -$0.06 | -$0.84 | -$0.43 | 48.81% | $325.00M | $140.95M | $227.00M | 61.05% | 02/19/2025 | |
IONS | Ionis Pharmaceuticals | -$0.85 | -$1.16 | -$0.72 | 37.93% | $144.00M | $129.88M | $134.00M | 3.17% | 11/06/2024 | |
IONS | Ionis Pharmaceuticals | -$0.41 | -$0.95 | -$0.24 | 74.74% | $188.00M | $146.02M | $225.00M | 54.09% | 08/01/2024 | |
IONS | Ionis Pharmaceuticals | -$0.68 | -$1.03 | -$0.77 | 25.24% | $131.00M | $138.28M | $119.00M | -13.94% | 05/07/2024 | |
IONS | Ionis Pharmaceuticals | -$1.18 | -$0.83 | -$0.06 | 92.77% | $152.00M | $174.76M | $325.00M | 85.97% | 02/21/2024 | |
IONS | Ionis Pharmaceuticals | -$0.16 | -$1.07 | -$0.85 | 20.56% | $160.00M | $132.90M | $144.00M | 8.35% | 11/02/2023 | |
IONS | Ionis Pharmaceuticals | -$0.56 | -$0.90 | -$0.41 | 54.44% | $134.00M | $138.83M | $188.00M | 35.42% | 08/09/2023 | |
IONS | Ionis Pharmaceuticals | -$0.27 | -$0.91 | -$0.68 | 25.27% | $142.00M | $128.12M | $131.00M | 2.25% | 05/03/2023 | |
IONS | Ionis Pharmaceuticals | $1.55 | -$0.92 | -$1.18 | -28.26% | $440.00M | $158.65M | $152.00M | -4.19% | 02/22/2023 | |
IONS | Ionis Pharmaceuticals | -$0.34 | -$0.74 | -$0.16 | 78.38% | $133.00M | $143.84M | $160.00M | 11.23% | 11/09/2022 | |
IONS | Ionis Pharmaceuticals | -$0.26 | -$0.62 | -$0.56 | 9.68% | $126.00M | $140.70M | $134.00M | -4.76% | 08/09/2022 | |
IONS | Ionis Pharmaceuticals | -$0.32 | -$0.71 | -$0.27 | 61.97% | $112.00M | $125.21M | $142.00M | 13.41% | 05/04/2022 | |
IONS | Ionis Pharmaceuticals | $0.81 | $0.28 | $1.55 | 453.57% | $290.00M | $259.15M | $440.00M | 69.79% | 02/24/2022 | |
IONS | Ionis Pharmaceuticals | -$0.22 | -$0.51 | -$0.34 | 33.33% | $160.00M | $158.38M | $133.00M | -16.02% | 11/03/2021 | |
IONS | Ionis Pharmaceuticals | -$0.23 | -$0.58 | -$0.26 | 55.17% | $146.00M | $129.94M | $126.00M | -3.03% | 08/04/2021 | |
IONS | Ionis Pharmaceuticals | -$0.35 | -$0.53 | -$0.32 | 39.62% | $133.00M | — | $112.00M | — | 05/05/2021 | |
IONS | Ionis Pharmaceuticals | $1.33 | $0.28 | $0.81 | 189.29% | $494.00M | $274.48M | $290.00M | 5.65% | 02/24/2021 |
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q3 | 2025-10-29 | $-0.61 | $-1.12 | 45.3 % |
| Q2 | 2025-07-30 | $0.85 | $0.16 | 431.3 % |
| Q1 | 2025-04-30 | $-0.93 | $-1.03 | 9.71 % |
| Q4 | 2025-02-19 | $-0.43 | $-0.84 | 48.8 % |
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q3 | 2025-10-29 | $157.00M | $130.27M | 20.5 % |
| Q2 | 2025-07-30 | $452.00M | $287.69M | 57.1 % |
| Q1 | 2025-04-30 | $132.00M | $122.51M | 7.75 % |
| Q4 | 2025-02-19 | $227.00M | $140.95M | 61.1 % |
Está previsto que Ionis Pharmaceuticals (IONS) presente resultados el febrero 18, 2026. Los últimos resultados se publicaron el octubre 29, 2025 para el Q3.
El BPA real fue de $-0.61, que superó la estimación de $-1.12.
Los ingresos reales fueron $157M, que superó la estimación de $130.3M.
Explora Estimaciones de beneficios, BPA e ingresos sobre todos los valores.